Table 6.
Comparison between the data about clinical hyperandrogenism between the three groups.
Group 1 | Group 2 | Group 3 | ||||
---|---|---|---|---|---|---|
Obese | Lean PCOS | Obese PCOS | ||||
n | n | n | ||||
Clinical hyperandrogenism | 60 | 53.3%∧∧ | 83 | 77.1%*** | 72 | 86.1% |
Hirsutism | 60 | 51.7%∧ | 82 | 72.0%*** | 72 | 84.7% |
Increased hair growth on the upper lip | 48 | 31.2%∧ | 67 | 53.7%** | 55 | 58.2% |
Increased hair growth on the sideburns | 46 | 23.9%∧ | 67 | 47.8%** | 55 | 58.2% |
Increased hair growth on the beard | 47 | 37.6% | 67 | 50.7%*** | 55 | 70.9%# |
Increased hair growth on the chest | 47 | 10.6%∧∧ | 67 | 34.3%** | 54 | 37.0% |
Increased hair growth on the abdomen | 48 | 27.1%∧∧∧ | 67 | 62.7%** | 56 | 60.7% |
Increased hair growth on the inner thighs | 48 | 14.6%∧∧∧ | 66 | 50.0%*** | 55 | 65.5% |
Acne | 50 | 4.0% | 70 | 12.9% | 62 | 1.6% |
Androgenic alopecia | 50 | 4.0% | 73 | 6.8% | 63 | 1.6% |
Ferriman-Gallwey score | 12 | 7.42 ± 2.47 | 37 | 9.16 ± 3.59 | 15 | 9.40 ± 4.17 |
# P < 0.05; between group 1 and group 3.
*P < 0.05; **P < 0.01; ***P < 0.001 between group 2 and group 3.
∧ P < 0.05; ∧∧ P < 0.01; ∧∧∧ P < 0.001 between group 1 and group 2.
n = number of patients.